Menu
Disease
A-Z
Health Topics
Developmental Pediatrics
General Pediatrics
Genetics
Immunodeficiencies
Infectious Diseases
Laboratory Medicine
Neonatology
Nutrition
Pediatric Cardiology
Pediatric Dermatology
View all Topics
Featured Articles
Urticaria (hives) and angioedema
Skin allergies
Circumcision
Anal itching
Anaphylaxis
Anal fissure
Kids Corner
Health and Knowledge with fun.
Drugs &
Calculators
Medical Calculators
Drug Calculators
Genetic Calculators
Growth Calculators
View all Calcualtors
Drug Index
ACE inhibitor
Alkylating agents
Allergies
View all Drugs
Poisoning Center
Aluminum phosphide
Anti-histaminics
Antidepressants
View all Drugs
Medical Eqipments
Monitors
Pumps
Incubators
View all Equipments
Diagnostic Aid
Get your diffrential
diagnosis.
Consult
& Posts
Ask a Doctor
Diagnostic Dilemma
Question of the Week
Pediatric Blogs
Spot Diagnosis
Grand Rounds
Pedi Poll
Pediatric
Journal
Current Issue
All Issues
Advance Access
About the Journal
Submit Article
Books
& Apps
Book Store
Pediatric Oncall
Medical Calculators
Vaccine Reminder
Pediatric Oncall Journal
Drug Center
Parenting
CME &
Videos
Upcoming Conferences
Conference Abstracts
MCQs
Videos
Vaccine
Reminder
Sign In
Question of Week
10yrs boy present to me with complaint of swelling...
Spot Diagnosis
Chylous ascitis
Cushing's disease
Diagnostic Dilemma
Rickets with low serum ceruloplasmin
Previous Question List
If a child who is 5.5 years old receives two doses...
In ADHD for how long should we prescribe medicines...
Is it necessary to give purgative with pyrantel pa...
A child with spastic diplegia has normal intellige...
In a child of 10 months of age having a platelet c...
Question of the Week
Question :
Posted On :
12 Aug 2014
can we use
Deflazacort
in nephrotic syndrome .give detailed guideline,where can i get reference
0
Expert Answer :
Dear Sir, Madam
Unfortunately I do not have an personal experience with the use of this agent in NS. These references may help you:
Drugs. 1995 Aug`50{2}:317-33.
Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Markham A, Bryson HM.
Adis International Limited, Auckland, New Zealand.
Pediatr Nephrol. 1997 Aug`11{4}:418-22.
A controlled study of
Deflazacort
in the treatment of idiopathic nephrotic syndrome.
Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P.
Département de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France.
Forty patients with steroid-dependent idiopathic nephrotic syndrome {INS}, a mean follow-up of 5.5 years, and a mean number of relapses of ten were blindly assigned to either
Deflazacort
{DFZ} {n = 20} or prednisone {PDN} {n = 20} according to a ratio of equivalence of DFZ, PDN = 0.8. This treatment was given for 1 year. The number of relapses was significantly lower in patients receiving DFZ. After 1 year, 12 remained in remission with DFZ compared with 2 with PDN. Growth velocity was not different in the two groups. Bone mineral content, assessed by quantitative computed tomography of L1 L2 vertebrae, decreased after 1 year by 6 percent in the DFZ group versus 12 percent in the PDN group {NS}. The mean body weight increase of plus3.9 plus, - 4.1 kg in the PDN group was higher than that of the DFZ group, plus1.7 plus, - 2.8 kg {P = 0.06}. Cushingoid symptoms tended to be less after 12 months in the DFZ group. In conclusion, this study shows that DFZ was more effective than PDN in limiting relapses in steroid-dependent INS, and that cushingoid symptoms, weight gain, and decrease in bone mineral content tended to be less marked with this drug than with PDN.
Answer Discussion :
No answer discussion available.
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
X
Sign In
Disease A-Z
Health Topics
Developmental Pediatrics
General Pediatrics
Genetics
Immunodeficiencies
Infectious Diseases
Laboratory Medicine
Neonatology
Nutrition
Pediatric Cardiology
Pediatric Dermatology
View all topics
Featured Articles
Urticaria (hives) and angioedema
Skin allergies
Circumcision
Anal itching
Anaphylaxis
Anal fissure
Kids Corner
Drugs & Calculators
Medical Calculators
Drug Calculators
Genetic Calculators
Growth Calculators
View all Calculators
Drug Index
ACE inhibitor
Alkylating agents
Allergies
View all Drugs
Poisoning Center
Aluminum phosphide
Anti-histaminics
Antidepressants
View all Drugs
Medical Eqipments
Monitors
Pumps
Incubators
View all Eqipments
Diagnostic Aid
Consult & Posts
Ask a Doctor
Diagnostic Dilemma
Question of the Week
Pediatric Blogs
Spot Diagnosis
Grand Rounds
Pedi Poll
Pediatric Oncall Journal
Current Issue
All Issues
Advance Access
About the Journal
Submit Article
Books & Apps
Book Store
Pediatric Oncall
Medical Calculators
Vaccine Reminder
Pediatric Oncall Journal
Drug Center
Parenting
CME & Videos
Upcoming Conferences
Conference Abstracts
MCQs
Videos
Vaccine Reminder
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0